Novo Nordisk unveils new drug to fight obesity, says 13% effective
HQ Team March 11, 2024: Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company.
Drugs
Health
Pharma
Drugs
Health
Pharma
Novo Nordisk says Ozempic reduces kidney disease progression
HQ Team March 6, 2024: Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney deaths in 24%.
Drugs
Health
Pharma
Novo Nordisk diabetes drug meets trial goals against insulin glargine
HQ Team January 9, 2023: Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in.
Drugs
Health
Pharma
Eli Lilly’s LillyDirect offers direct access to obesity medication
HQ team January 6, 2024: Eli Lilly, the pharmaceutical company will now be selling its weightless drug directly to the consumer via its.
Drugs
Health
Medical
Novel long-acting GLP-1 agonist offers hope for type 2 diabetics
HQ Team November 4, 2023: Scientists at the University of Tabriz, Iran, have done pioneering work on a long-acting GLP-1 agonist that holds.
Drugs
Health
Pharma
Novo Nordisk’s weight-loss drug Wegovy enters the UK market
HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a.
Drugs
Health
Medical
Oral semaglutide reduces HbA1c, weight in Type 2 diabetics, study reveals
HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the.